From March 10, 2023 to April 10, 2023, the company has repurchased 2,210,500 shares, representing 1.73% for INR 3,149.96 million. With this, the company has completed the repurchase of 2,210,500 shares, representing 1.73% for INR 3,149.96 million under the buyback announced on March 10, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,381 INR | -0.59% | -1.19% | +14.27% |
May. 03 | INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh | RE |
May. 02 | Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.27% | 3.58B | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.22% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.66B |
- Stock Market
- Equities
- AJANTPHARM Stock
- News Ajanta Pharma Limited
- Tranche Update on Ajanta Pharma Limited's Equity Buyback Plan announced on March 10, 2023.